Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

0.87USD
4:51pm BST
Change (% chg)

$0.02 (+2.85%)
Prev Close
$0.85
Open
$0.86
Day's High
$0.87
Day's Low
$0.84
Volume
92,100
Avg. Vol
175,318
52-wk High
$3.78
52-wk Low
$0.61

Latest Key Developments (Source: Significant Developments)

Catabasis Pharmaceuticals reports third quarter financial results
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc :Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress.Q3 loss per share $0.31.Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S.Catabasis Pharmaceuticals Inc - co's current operating plan provides for cash to fund operations through august 2018​.  Full Article

BRIEF-Catabasis Pharmaceuticals Reports Q1 Loss Per Share $0.29

* CATABASIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS